Skip Navigation

JNCI Monographs 2003 2003(31):20-28;
© 2003 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Castellsagué, X.
Right arrow Articles by Muñoz, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castellsagué, X.
Right arrow Articles by Muñoz, N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute Monographs, No. 31, 20-28, 2003
© 2003 Oxford University Press


ARTICLE

Chapter 3: Cofactors in Human Papillomavirus Carcinogenesis—Role of Parity, Oral Contraceptives, and Tobacco Smoking

Xavier Castellsagué, Nubia Muñoz

Affiliations of authors: X. Castellsagué, Institut Català d’Oncologia, Servei d’Epidemiologia i Registre del Càncer, L’Hospitalet de Llobregat, Barcelona, Spain; N. Muñoz, International Agency for Research on Cancer, Lyon, France.

Correspondence to: Xavier Castellsagué, M.D., Ph.D., M.P.H., Institut Català d’Oncologia, Servei d’Epidemiologia i Registre del Càncer, Gran via s/n, km 2.7, 08907 L’Hospitalet de Llobregat, Barcelona, Spain (e-mail: xcastellsague{at}ico.scs.es).

It is now well established that infection with oncogenic human papillomavirus (HPV) types is the necessary cause of cervical cancer (CC) and its immediate precursor cervical intraepithelial neoplasia 3. However, HPV infection alone may not be sufficient to cause CC, and other exogenous and endogenous factors may exist that, in conjunction with HPV, influence the risk of progression from cervical HPV infection to CC. In this chapter, we review the evidence for the role of parity, oral contraceptive (OC) use, and tobacco smoking in CC. We also discuss limitations and methodologic problems encountered in assessing available data and outline recommendations for future research. Based on key studies on high-grade squamous intraepithelial lesions (HSILs) and CC conducted among HPV-positive women, it can be concluded that high parity, smoking, and less consistently long-term OC use are cofactors that may modulate the risk of progression from HPV infection to HSIL/CC. From a public health point of view, parity seems to be the behavioral cofactor explaining the highest proportion of CC cases among HPV-infected women. Smoking and long-term OC use may have a similar impact in populations that are heavily exposed to HPV and to these cofactors. Large prospective and retrospective cohort studies of HSIL and CC among middle-aged women in which several markers of HPV exposure are used and HPV persistence is documented would be valuable to study the role of these and other cofactors in HPV carcinogenesis. If confirmed, our conclusions may imply that multiparous women, women who are smokers, and women on long-term OC use may need closer surveillance for cytologic abnormalities and HPV infections than women in the general population.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. K. Hussain, M. M. Madeleine, L. G. Johnson, Q. Du, M. Malkki, H.-W. Wilkerson, F. M. Farin, J. J. Carter, D. A. Galloway, J. R. Daling, et al.
Cervical and Vulvar Cancer Risk in Relation to the Joint Effects of Cigarette Smoking and Genetic Variation in Interleukin 2
Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1790 - 1799.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. E. Castle, C. Meyers, S. Alam, and M. J. Conway
How Does Tobacco Smoke Contribute to Cervical Carcinogenesis?
J. Virol., June 15, 2008; 82(12): 6084 - 6086.
[Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. L. Tornesello, M. L. Duraturo, P. Giorgi-Rossi, M. Sansone, R. Piccoli, L. Buonaguro, and F. M. Buonaguro
Human papillomavirus (HPV) genotypes and HPV16 variants in human immunodeficiency virus-positive Italian women
J. Gen. Virol., June 1, 2008; 89(6): 1380 - 1389.
[Abstract] [Full Text] [PDF]


Home page
Int J STD AIDSHome page
K Syrjanen, P Naud, S Derchain, C Roteli-Martins, A Longatto-Filho, S Tatti, M Branca, M Erzen, L S Hammes, J Matos, et al.
Drug addiction is not an independent risk factor for oncogenic human papillomavirus infections or high-grade cervical intraepithelial neoplasia: case-control study nested within the Latin American Screening study cohort
Int J STD AIDS, April 1, 2008; 19(4): 251 - 258.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
A. K. Chaturvedi, E. A. Engels, E. S. Gilbert, B. E. Chen, H. Storm, C. F. Lynch, P. Hall, F. Langmark, E. Pukkala, M. Kaijser, et al.
Second Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk
J Natl Cancer Inst, November 7, 2007; 99(21): 1634 - 1643.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. E. Wood, Z. Chen, J. M. Cline, B. E. Miller, and R. D. Burk
Characterization and Experimental Transmission of an Oncogenic Papillomavirus in Female Macaques
J. Virol., June 15, 2007; 81(12): 6339 - 6345.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. T. Goodman, Y. B. Shvetsov, K. McDuffie, L. R. Wilkens, X. Zhu, A. A. Franke, C. C. Bertram, B. Kessel, M. Bernice, C. Sunoo, et al.
Hawaii Cohort Study of Serum Micronutrient Concentrations and Clearance of Incident Oncogenic Human Papillomavirus Infection of the Cervix
Cancer Res., June 15, 2007; 67(12): 5987 - 5996.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
C. Fakhry, G. D'souza, E. Sugar, K. Weber, E. Goshu, H. Minkoff, R. Wright, E. Seaberg, and M. Gillison
Relationship between Prevalent Oral and Cervical Human Papillomavirus Infections in Human Immunodeficiency Virus-Positive and -Negative Women
J. Clin. Microbiol., December 1, 2006; 44(12): 4479 - 4485.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. Vaccarella, R. Herrero, M. Dai, P. J.F. Snijders, C. J.L.M. Meijer, J. O. Thomas, P. T. Hoang Anh, C. Ferreccio, E. Matos, H. Posso, et al.
Reproductive Factors, Oral Contraceptive Use, and Human Papillomavirus Infection: Pooled Analysis of the IARC HPV Prevalence Surveys.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2148 - 2153.
[Abstract] [Full Text] [PDF]


Home page
JAOA: Journal of the American Osteopathic AssociationHome page
B. A. Weaver
Epidemiology and Natural History of Genital Human Papillomavirus Infection
J Am Osteopath Assoc, March 1, 2006; 106(suppl_1): S2 - S8.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. S. Shields, L. A. Brinton, R. D. Burk, S. S. Wang, S. J. Weinstein, R. G. Ziegler, Y. Y. Studentsov, M. McAdams, and M. Schiffman
A Case-Control Study of Risk Factors for Invasive Cervical Cancer among U.S. Women Exposed to Oncogenic Types of Human Papillomavirus
Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1574 - 1582.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.